MedTrace Logo

Effects of Terlipressin When Usual Somatostatin or Octreotide Dose Fails

NCT02311608 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1320

Last updated 2014-12-08

No results posted yet for this study

Summary

To observe and access the Effects and safety of terlipressin or high dose somatostatin/octreotide when usual dose somatostatin/octreotide fail to achieve hemostasis in patients with acute variceal bleeding.

Conditions

Interventions

DRUG

Terlipressin

administered as a first-line medicine or as salvage

DRUG

Usual Dose Somatostatin/Octreotide

administered as a first-line medicine or as salvage

DRUG

High Dose Somatostatin/Octreotide

administered as salvage

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Shiyao Chen, Professor · Shanghai Zhongshan Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-02-29
Completion
2016-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02311608 on ClinicalTrials.gov